Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001090890 | SCV001246652 | pathogenic | not provided | 2018-02-01 | criteria provided, single submitter | clinical testing | |
Center for Medical Genetics Ghent, |
RCV000024110 | SCV001437201 | pathogenic | Brittle cornea syndrome 2 | 2020-08-01 | criteria provided, single submitter | clinical testing | |
Laboratory of Medical Genetics, |
RCV000024110 | SCV001976994 | pathogenic | Brittle cornea syndrome 2 | 2021-10-01 | criteria provided, single submitter | clinical testing | PVS1, PM2, PP3, PP5 |
Genome Diagnostics Laboratory, |
RCV002276571 | SCV002566072 | pathogenic | Ehlers-Danlos syndrome | 2021-04-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001090890 | SCV003525528 | pathogenic | not provided | 2023-12-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys325Leufs*2) in the PRDM5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRDM5 are known to be pathogenic (PMID: 21664999, 26395458). This variant is present in population databases (rs766853150, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with brittle cornea syndrome (PMID: 21664999, 33739556). ClinVar contains an entry for this variant (Variation ID: 31114). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000024110 | SCV000045401 | pathogenic | Brittle cornea syndrome 2 | 2011-06-10 | no assertion criteria provided | literature only |